Does LOBAPLATIN Cause Myelosuppression? 84 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Myelosuppression have been filed in association with LOBAPLATIN. This represents 42.2% of all adverse event reports for LOBAPLATIN.
84
Reports of Myelosuppression with LOBAPLATIN
42.2%
of all LOBAPLATIN reports
1
Deaths
50
Hospitalizations
How Dangerous Is Myelosuppression From LOBAPLATIN?
Of the 84 reports, 1 (1.2%) resulted in death, 50 (59.5%) required hospitalization, and 9 (10.7%) were considered life-threatening.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOBAPLATIN. However, 84 reports have been filed with the FAERS database.
What Other Side Effects Does LOBAPLATIN Cause?
White blood cell count decreased (21)
Platelet count decreased (17)
Off label use (15)
Nausea (14)
Neutrophil count decreased (14)
Bone marrow failure (12)
Vomiting (11)
Hepatic function abnormal (10)
Rash (10)
Asthenia (9)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which LOBAPLATIN Alternatives Have Lower Myelosuppression Risk?
LOBAPLATIN vs LOFEXIDINE
LOBAPLATIN vs LOMITAPIDE
LOBAPLATIN vs LOMUSTINE
LOBAPLATIN vs LONAPEGSOMATROPIN-TCGD
LOBAPLATIN vs LONCASTUXIMAB TESIRINE-LPYL